✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
Herein, we presented acase of a hemodialysis patient with FMF, who developed rhabdomyolysis due to concomitant use of colchicine and clarithromycin for pneumonia treatment.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Familial Mediterranean fever (FMF) is an autosomal recessive hereditary disease characterized by recurrent attacks of fever,usually accompanied by sterile polyserositis.
📊
Key Findings & Data:Although colchicine is the main medical treatment option for FMF, potentialadverse effects and drug interactions should be considered during the follow-up of these patients.
💡
Conclusion & Impact:Herein, we presented acase of a hemodialysis patient with FMF, who developed rhabdomyolysis due to concomitant use of colchicine and clarithromycin for pneumonia treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
Familial Mediterranean fever (FMF) is an autosomal recessive hereditary disease characterized by recurrent attacks of fever,usually accompanied by sterile polyserositis. Although colchicine is the main medical treatment option for FMF, potentialadverse effects and drug interactions should be considered during the follow-up of these patients. Herein, we presented acase of a hemodialysis patient with FMF, who developed rhabdomyolysis due to concomitant use of colchicine and clarithromycin for pneumonia treatment.
🔖
Cite This Article
ABEDI, A. H., EROĞLU, E., KOÇYİĞİT, İ., ÜNAL, A., SİPAHİOĞLU, M. H., TOKGÖZ, B., OYMAK, O. (2019). Colchicine-and Clarithromycin-Induced Rhabdomyolysis in a Hemodialysis Patient with Familial Mediterranean Fever. Turkish journal of nephrology (Online), Cilt: 28 - Sayı: 1, 81–83. https://ajindex.com/articles/374909